Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Aluminium may substitute copper on price volatility
All the base metals on the London Metal Exchange continue to rise higher and higher, aided principally by the growing investor support, improving global economic sentiment and inflation in smelter operational costs. At this point, with investors deciding to pin their faith on positives like good showing by China and India; and Euro zone breaking out of recession and not to be bothered by still wobbling US economy, copper is bid at $7,454 a tonne and aluminium at $2,293 a tonne, for ready delivery.

GE seeks sale of security unit
General Electric Co (GE) is seeking to sell its security unit, which builds surveillance cameras and alarms, and may fetch about $2 billion, people aware of the details said.

News of the day

31 MLAs of JMM-led coalition have criminal cases against them
The new five-party coalition in Jharkhand which is all set to assume power tomorrow has 31 MLAs with criminal cases against them.
Business Ideas

Aurobindo Pharma receives Swissmedic approval

Aurobindo Pharma Limited announced that it received two approvals from Swissmedic, a Switzerland government agency for therapeutic products, for the licence of Amlodipine APL 5mg and 10 mg tablets and Melformin APL 500 mg, 850 mg and 1,000 mg tablets. - Road to recovery: Gujarat"s pharma share rises to 30% - Ranbaxy to launch Rocaltrol(R) in US soon - Cipla to raise Rs 1,500 cr by issue of shares - Drug to treat swine flu to be available in retail mkt - JB Chemicals gets USFDA nod for its anti-allergic tablets - GSK to launch "promecta" in India by 2009-end Amlodipine fall under cardio vascular disorder therapeutic segment and is used in treatment of hypertension, along or in combination with other drugs. Melformin is used in treatment of diabetes mellitus (type 2) in adults and children. Aurobindo now has four product approvals from Swissmedic. It also received the final approval for Risperidone oral solution 1mg/ml. This is generic equivalent of Risperdal oral solution 1mg/ml of Ortho-McNeil Janssen. The drug, which comes under neurological segment, is used in the treatment of schizophrenia. The product has a market size of about $ 68 million (about Rs 333.3 crore) for the 12 months ending March 2009. The product would be launched shortly, the company said in a filing to the Bombay Stock Exchange(BSE). Aurobindo now has 102 abbreviated new drug approvals (ANDA) including 74 final and 28 tentative approvals from the USFDA. Its stock traded at Rs 705.85 on Monday, up 1.46 per cent from the previous close of Rs 695.7 on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009